Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 3,114 shares at $88.12 ($274K) on 2019-02-04, disclosed to the SEC on 2019-02-06.
Seasonal sale ($274k) by Chief Research Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.12 | 1,375 | $121K | 44.1% |
| 2 | $88.17 | 401 | $35K | 12.9% |
| 3 | $88.17 | 669 | $59K | 21.5% |
| 4 | $88.17 | 669 | $59K | 21.5% |
| Total | $88.15 avg | 3,114 | $274K | 100% |
| Filing → |
| NBIX | SELL | 2020-11-16 | $410K | — | Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-20 | $10.8M | — | Filing → |